Paper40287635
C-reactive protein to albumin ratio combined with the Systemic Inflammatory Response Index predicts the prognosis of patients undergoing radical hepatectomy.
Lu SL and 8 others. BMC Cancer, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. C-reactive protein to albumin ratio combined with the Systemic Inflammatory Response Index predicts the prognosis of patients undergoing radical hepatectomy. Papers, record 40287635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40287635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- C-reactive protein to albumin ratio combined with the Systemic Inflammatory Response Index predicts the prognosis of patients undergoing radical hepatectomy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| C-Reactive Protein | Major topic |
| Liver Neoplasms | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Hepatectomy | Major topic |
| Inflammation | Major topic |
| Serum Albumin | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Prognosis | |
| Nomograms | |
| Aged | |
| ROC Curve | |
| Adult | |
| Biomarkers, Tumor | |
| Retrospective Studies |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024JJB140755 | Guangxi Natural Youth Science Foundation | PubMed | ||
| 82260345 | National Natural Science Foundation of China | PubMed | ||
| G202003008 | the "139" Plan for Training High-level Backbone Medical Talents in Guangxi | PubMed | ||
| AB22080066 | Guangxi Key Technologies R&D Program | PubMed | ||
| 2024AC43021 | Guangxi Science and Technology Base and Talent Specialization | PubMed | ||
| AD25069061 | Specific Research Project of Guangxi for Research Bases and Talents | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36091335 | Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/36091335 | PubMed |
| 2 | 36690297 | Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC. | Cell Mol Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/36690297 | PubMed |
| 3 | 25271081 | Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/25271081 | PubMed |
| 4 | 30809789 | Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. | Semin Liver Dis | 2019 | https://conductscience.org/library/papers/30809789 | PubMed |
| 5 | 29299446 | Comparing baseline characteristics between groups: an introduction to the CBCgrps package. | Ann Transl Med | 2017 | https://conductscience.org/library/papers/29299446 | PubMed |
| 6 | 26356714 | Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/26356714 | PubMed |
| 7 | 32026332 | Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. | J Gastrointest Surg | 2021 | https://conductscience.org/library/papers/32026332 | PubMed |
| 8 | 35116492 | Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116492 | PubMed |
| 9 | 32047496 | Macrophage Phenotype and Function in Liver Disorder. | Front Immunol | 2019 | https://conductscience.org/library/papers/32047496 | PubMed |
| 10 | 36084663 | Hepatocellular carcinoma. | Lancet | 2022 | https://conductscience.org/library/papers/36084663 | PubMed |
| 11 | 32499786 | The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. | Front Immunol | 2020 | https://conductscience.org/library/papers/32499786 | PubMed |
| 12 | 28886327 | Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis. | Cell Mol Biol (Noisy-le-grand) | 2017 | https://conductscience.org/library/papers/28886327 | PubMed |
| 13 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 14 | 28430597 | Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. | Oncotarget | 2017 | https://conductscience.org/library/papers/28430597 | PubMed |
| 15 | 32963635 | Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis. | Dis Markers | 2020 | https://conductscience.org/library/papers/32963635 | PubMed |
| 16 | 34665953 | Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma. | Clin Mol Hepatol | 2022 | https://conductscience.org/library/papers/34665953 | PubMed |
| 17 | 31433891 | The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. | Liver Int | 2019 | https://conductscience.org/library/papers/31433891 | PubMed |
| 18 | 29951199 | C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. | Clin Pract (Lond) | 2018 | https://conductscience.org/library/papers/29951199 | PubMed |
| 19 | 34442866 | Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. | Microorganisms | 2021 | https://conductscience.org/library/papers/34442866 | PubMed |
| 20 | 25190127 | The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. | Ann Surg Oncol | 2015 | https://conductscience.org/library/papers/25190127 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806231 | Efficacy and safety of adjuvant targeted therapy plus immunotherapy in hepatocellular carcinoma patients with high-risk recurrence factors after hepatectomy. | Updates Surg | 2026 | https://conductscience.org/library/papers/42806231 | PubMed |
| 42604372 | Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42604372 | PubMed |
| 42325771 | Laparoscopic vs. open surgery for early-stage endometrial cancer: effect on inflammatory factors and quality of life. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42325771 | PubMed |
| 40652175 | Prognostic evaluation of albumin-associated inflammatory indices (LAR, NAR, MAR, FAR, SII/Alb, SIRI/Alb, NPAR, and CAR) in preterm premature rupture of membranes (PPROM) pregnancies. | BMC Pregnancy Childbirth | 2025 | https://conductscience.org/library/papers/40652175 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40287635
GET https://conductscience.org/api/papers/v1/40287635/references?page=2